Abstract | BACKGROUND: OBJECTIVES: In the current study, we aimed to assess the effects of simvastatin on serum levels of adiponectin in patients with dyslipidemia, recruited from Ghaem Hospital, Mashhad, Iran. MATERIALS AND METHODS: A total of 102 patients with dyslipidemia were treated with simvastatin or placebo during a double-blind, cross-over, placebo-controlled trial. The adiponectin levels were measured before and after each treatment period. Seventy seven participants completed the study. RESULTS: CONCLUSIONS:
|
Authors | Atefeh Moezzi, Seyyed Mohammad Reza Parizadeh, Shima Tavallaie, Mohsen Mazidi, Fariba Afzali, Afrouz Adab, Gordon Ferns, Majid Ghayour Mobarhan |
Journal | Iranian Red Crescent medical journal
(Iran Red Crescent Med J)
Vol. 16
Issue 8
Pg. e6915
(Aug 2014)
ISSN: 2074-1804 [Print] Estonia |
PMID | 25389496
(Publication Type: Journal Article)
|